NorthWest Biotherapeutics Inc (NWBO)

[Troymister]

No disagreement with your overall sentiment. However, as a seven-year and now holder of a significant amount of NWBO, I believe that from a communications perspective, the company has done a very poor job of protecting stockholder value. Done right, this stock should have held $2 with the revelation from last week's conference. Instead we have to build from 65 cents--my average price over seven years. That money could have been used elsewhere over seven years.